Literature DB >> 1206481

Do you need a pharmacokinetic model, and, if so, which one?

J G Wagner.   

Abstract

Mesh:

Substances:

Year:  1975        PMID: 1206481     DOI: 10.1007/bf01059477

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN: 0090-466X


× No keyword cloud information.
  17 in total

1.  Pharmacokinetics of diphenhydramine in man.

Authors:  K S Albert; M R Hallmark; E Sakmar; D J Weidler; J G Wagner
Journal:  J Pharmacokinet Biopharm       Date:  1975-06

2.  Per cent absorbed time plots derived from blood level and/or urinary excretion data.

Authors:  J G WAGNER; E NELSON
Journal:  J Pharm Sci       Date:  1963-06       Impact factor: 3.534

3.  Quantitative pooling of Michaelis-Menten equations in models with parallel metabolite formation paths.

Authors:  A J Sedman; J G Wagner
Journal:  J Pharmacokinet Biopharm       Date:  1974-04

4.  Linear and nonlinear kinetics of drug elimination. I. Kinetics on the basis of a single capacity-limited pathway of elimination with or without simultaneous supply-limited elimination.

Authors:  C A van Ginneken; J M van Rossum; H L Fleuren
Journal:  J Pharmacokinet Biopharm       Date:  1974-10

5.  Application of the Wagner-Nelson absorption method to the two-compartment open model.

Authors:  J G Wagner
Journal:  J Pharmacokinet Biopharm       Date:  1974-12

6.  Curve fitting by spline and Akima methods: possibility of interpolation error and its suppression.

Authors:  J Fried; S Zietz
Journal:  Phys Med Biol       Date:  1973-07       Impact factor: 3.609

7.  General treatment of linear mammillary models with elimination from any compartment as used in pharmacokinetics.

Authors:  L Z Benet
Journal:  J Pharm Sci       Date:  1972-04       Impact factor: 3.534

8.  Influence of route of administration on drug availability.

Authors:  M Rowland
Journal:  J Pharm Sci       Date:  1972-01       Impact factor: 3.534

9.  Methotrexate pharmacokinetics.

Authors:  K B Bischoff; R L Dedrick; D S Zaharko; J A Longstreth
Journal:  J Pharm Sci       Date:  1971-08       Impact factor: 3.534

10.  Blood levels of drug at the equilibrium state after multiple dosing.

Authors:  J G Wagner; J I Northam; C D Alway; O S Carpenter
Journal:  Nature       Date:  1965-09-18       Impact factor: 49.962

View more
  31 in total

1.  Performance of diltiazem tablet and multiparticulate osmotic formulations in the dog.

Authors:  S C Sutton; K Engle; R A Deeken; K E Plute; R D Shaffer
Journal:  Pharm Res       Date:  1990-08       Impact factor: 4.200

2.  Linear pharmacokinetic models and vanishing exponential terms: implications in pharmacokinetics.

Authors:  J G Wagner
Journal:  J Pharmacokinet Biopharm       Date:  1976-10

3.  Linear pharmacokinetic equations allowing direct calculation of many needed pharmacokinetic parameters from the coefficients and exponents of polyexponential equations which have been fitted to the data.

Authors:  J G Wagner
Journal:  J Pharmacokinet Biopharm       Date:  1976-10

Review 4.  Noncompartmental versus compartmental modelling in clinical pharmacokinetics.

Authors:  W R Gillespie
Journal:  Clin Pharmacokinet       Date:  1991-04       Impact factor: 6.447

5.  Scaling of pharmacokinetics across paediatric populations: the lack of interpolative power of allometric models.

Authors:  Massimo Cella; Catherijne Knibbe; Saskia N de Wildt; Joop Van Gerven; Meindert Danhof; Oscar Della Pasqua
Journal:  Br J Clin Pharmacol       Date:  2012-09       Impact factor: 4.335

6.  Quantitative biodistribution and pharmacokinetics of multimodal gadolinium-based nanoparticles for lungs using ultrashort TE MRI.

Authors:  Andrea Bianchi; Sandrine Dufort; François Lux; Arnaud Courtois; Olivier Tillement; Jean-Luc Coll; Yannick Crémillieux
Journal:  MAGMA       Date:  2013-10-30       Impact factor: 2.310

7.  Frequency response method in pharmacokinetics.

Authors:  L Dedík; M Durisová
Journal:  J Pharmacokinet Biopharm       Date:  1994-08

Review 8.  Applications of a recirculatory stochastic pharmacokinetic model: limitations of compartmental models.

Authors:  D P Vaughan; I Hope
Journal:  J Pharmacokinet Biopharm       Date:  1979-04

9.  Curve fitting and modeling in pharmacokinetics and some practical experiences with NONLIN and a new program FUNFIT.

Authors:  P V Pedersen
Journal:  J Pharmacokinet Biopharm       Date:  1977-10

10.  A model-independent proof of Dost's law of corresponding areas.

Authors:  D P Vaughan
Journal:  J Pharmacokinet Biopharm       Date:  1977-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.